Cybin Inc. (NEO:CYBN) (NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited...
The article News You Might Have Missed: Nov 14th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
October was a pretty brutal month for the psychedelic stock market no matter which way you look at it. While the rest of the stock market...
The non-profit trade association received a high level of interest from multiple branches of government The post PsyCan aims to be ‘go-to’ psychedelics...
The non-profit trade association received a high level of interest from multiple branches of government The post PsyCan aims to be ‘go-to’ psychedelic...
Cybin Inc. (NEO:CYBN | (NYSE AMERICAN:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to announce...
Wonderland took place Nov. 3-5 in Miami. The post Wonderland 2022 Hosts Impressive Speaker Lineup appeared first on Green Market Report.
Big Pharma feeling pressure to join forces with psychedelics firms to develop mental health treatments The post Can Psychedelics Solve Big Pharma’s Mental...
Cybin Inc. (NEO:CYBN | NYSE American:CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, is pleased to announce...
Despite a challenging economy, psychedelics companies have accelerated development. The post Recession Predictions Not Slowing Psychedelics Industry appeared...